MediciNova, Inc. (MNOV)

NASDAQ: MNOV · USD

$1.44

+0.03 (+2.1%)· Recorded snapshot

Market cap	70.9M
Revenue (ttm)	920.5K
Net income (ttm)	-10.8M
EPS (ttm)	-$0.22
Shares out	49.2M
Volume	23,865
Beta	0.61

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 920.5K
Net income (ttm): -10.8M
EPS (ttm): -$0.22
Market cap: 70.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-25.6

P25 n/aP50 n/aP75 n/a

ROIC-17.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All MNOV indicators

Market & fundamental data

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001226616
Company name	MediciNova, Inc.
Country	United States
Country code	US
CUSIP number	58468P206
Earnings date	2026-11-11
Earnings time	amc
Employees	6
Employees change	-7
Employees growth	-53.85%
Enterprise value	$45.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2000
Industry	Biotechnology
IPO date	2005-02-08
Is primary listing	Yes
Is SPAC	No
ISIN number	US58468P2065
Last 10-K release date	2026-03-10
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$70.9M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$1.44
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	MNOV
U.S. state	California
Website	https://medicinova.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-15.19%
EV/Sales	47.91x
FCF / EV yield	-20.69%
FCF yield	-13.15%
Forward EV/Sales	529.26x
Forward P/S	832.86x
P/B ratio	1.86x
P/S ratio	75.4x
Price / tangible book value	3.03x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	37.75%
Operating margin	-1,287.41%
Pretax margin	-1,167.55%
Profit per employee	$-1.8M
Revenue per employee	$153,414
ROA	-16.41%
ROA (5Y)	-11.46%
ROCE	-31.62%
ROE	-25.56%
ROE (5Y)	-17.8%
ROIC	-17.52%
SBC / revenue	100.25%
Tax / revenue	0.65%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	0
Gross profit growth	1,803.8%
Gross profit growth (Q)	1,641.15%
Gross profit growth 5Y	-38.66%
Net income growth quarters	3
Net income growth years	0
Revenue growth	583.87%
Revenue growth (Q)	240.6%
Revenue growth (QoQ)	145.18%
Revenue growth 5Y	-25.46%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-13,724
Depreciation and amortization	$19,138
EBIT	$-11.9M
EBITDA	$-11.8M
EPS	$-0.22
FCF per share	$-0.19
Financing cash flow	$244,018
Free cash flow	$-9.1M
Free cash flow minus SBC	$-10M
Gross profit	$347,443
Income taxes	$5,994
Investing cash flow	$-13,724
Net cash flow	$-8.8M
Net income	$-10.8M
Operating cash flow minus SBC	$-10M
Operating income	$-11.9M
Revenue	$920,481
Stock-based compensation	$922,783

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-2.69
Book value per share	$0.76
Debt / equity	0
Goodwill	$9.6M
Long-term assets	$14.5M
Long-term liabilities	$201,792
Net cash (debt)	$25.3M
Net cash / market cap	36.45%
Net cash growth	-25.5%
Net debt / equity	-0.68
Piotroski F-Score	3
Property, plant and equipment	$111,803
Shareholders' equity	$37.3M
Tangible book value	$22.9M
Tangible book value per share	$0.46
Total assets	$40.4M
Total cash	$25.4M
Total debt	$117,038
Total liabilities	$3.2M
WACC	7.62%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.02
Current assets	$25.9M
Current liabilities	$3M
Current ratio	8.75
Net working capital	$-2.3M
Quick ratio	8.58
Working capital	$23M
Working capital turnover	0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.21%
Dividend yield	0%
Shareholder yield	-0.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-79.69%
10Y return CAGR	-14.74%
10Y total return	-79.69%
150-day SMA	$1.51
15Y price change	-40.74%
15Y return CAGR	-3.43%
15Y total return	-40.74%
1D price change	2.13%
1M price change	-44.19%
1M total return	-44.19%
1W price change	5.88%
1W total return	5.88%
1Y price change	19.5%
1Y return CAGR	19.52%
1Y total return	19.5%
20-day SMA	$1.50
200-day SMA	$1.51
3M price change	9.09%
3M total return	9.09%
3Y price change	-25%
3Y return CAGR	-9.14%
3Y total return	-25%
50-day SMA	$1.79
50-day SMA vs 200-day SMA	50over200
52-week high	$3.90
52-week high date	2026-09-17
52-week low	$1.17
52-week low date	2025-10-30
5Y price change	-58.5%
5Y return CAGR	-16.13%
5Y total return	-58.5%
6M price change	5.11%
6M total return	5.11%
All-time high	$16.12
All-time high date	2006-12-13
All-time low	$1.12
All-time low date	2024-08-12
Average true range (ATR)	$0.13
Average volume	97.6K
Beta (1Y)	0.53
Beta (2Y)	0.53
Beta (5Y)	0.61
Change from 52-week high	-63.08%
Change from 52-week low	23.29%
Change from all-time high	-91.07%
Change from all-time low	28.57%
Change from open	1.41%
Day's gap	0.71%
Dollar volume	$34,366
High price	$1.53
Low price	$1.40
Monthly RSI	46.91
Open price	$1.42
Position in 52-week range	30.77%
Premarket change	5.67%
Premarket close	$1.41
Premarket price	$1.49
Previous close	$1.41
Price vs 150-day SMA	-4.38%
Price vs 20-day SMA	-4.26%
Price vs 200-day SMA	-4.89%
Price vs 50-day SMA	-19.46%
Relative volume	0.24
RSI	39.61
Sharpe ratio	0.55
Sharpe ratio (3Y)	0.14
Sharpe ratio (5Y)	-0.04
Sortino ratio	1.17
Sortino ratio (3Y)	0.37
Sortino ratio (5Y)	0.03
Volume	23.9K
Weekly RSI	47.28
YTD price change	9.92%
YTD total return	9.92%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	42.9M
Float percentage	87.25%
Shares change (QoQ)	0%
Shares change (YoY)	0.21%
Shares held by insiders	2.87%
Shares held by institutions	10.56%
Shares outstanding	49.2M
Short % of float	0.68%
Short % of shares	0.59%
Short ratio	0.4 days

Deeper analysis on MNOV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MNOV report

Is a complete MNOV research report available?

No complete published report is available for MediciNova, Inc. (MNOV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

MediciNova, Inc. (MNOV)

Price

Financial snapshot

Fair-value bridge

Latest news · MNOV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MNOV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MNOV

Frequently asked questions